Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

AddLife

179.70 SEK

-1.75 %

Less than 1K followers

ALIF B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-1.75 %
-9.70 %
+1.07 %
-6.31 %
+30.88 %
+30.69 %
+51.77 %
+42.10 %
+656.50 %

AddLife operates in the medical technology industry and focuses on the development, manufacturing and distribution of medical equipment and laboratory products. The company's products are aimed at healthcare institutions and research laboratories. The business is global with a primary presence in Europe, North America and Asia. AddLife was founded in 2015 and is headquartered in Stockholm, Sweden.

Read more
Market cap
22B SEK
Turnover
8.84M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4.2.
2026

Annual report '25

28.4.
2026

Interim report Q1'26

6.5.
2026

General meeting '26

All
Webcasts
Press releases
ShowingAll content types
Press release12/1/2025, 2:00 PM

AddLife acquires Opitek International ApS

AddLife
Press release12/1/2025, 1:00 PM

AddLife acquires Pharmacold A/S

AddLife
Regulatory press release10/23/2025, 5:45 AM

Interim Report January 1 – September 30, 2025

AddLife

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release7/15/2025, 5:45 AM

Interim Report January 1 – June 30, 2025

AddLife
Regulatory press release5/8/2025, 3:45 PM

Annual General Meeting of AddLife AB 8 May 2025

AddLife
Regulatory press release4/25/2025, 5:45 AM

Margin improvement continues, the debt level is reduced, and acquisition activity increases

AddLife
Regulatory press release4/4/2025, 7:00 AM

AddLife's Annual Report for 2024 is now published

AddLife
Press release4/1/2025, 1:00 PM

AddLife acquires Edge Medical Ltd

AddLife
Regulatory press release3/27/2025, 10:00 AM

Notice to attend the Annual General Meeting of AddLife AB (publ)

AddLife
Regulatory press release2/5/2025, 6:45 AM

AddLife: Year-end Report 1 January - 31 December 2024

AddLife
Regulatory press release10/31/2024, 1:00 PM

Change in the number of shares and votes in AddLife AB

AddLife
Regulatory press release10/23/2024, 5:45 AM

AddLife: Interim Report 1 January - 30 September 2024

AddLife
Regulatory press release7/15/2024, 5:45 AM

AddLife: Interim Report 1 January - 30 June 2024

AddLife
Press release7/5/2024, 5:45 AM

AddLife acquires BonsaiLab

AddLife
Regulatory press release6/28/2024, 12:00 PM

Change in the number of shares and votes in AddLife AB

AddLife
Regulatory press release5/8/2024, 3:30 PM

Annual General Meeting of AddLife AB 8 May 2024

AddLife
Regulatory press release4/24/2024, 5:45 AM

AddLife: Interim Report 1 January - 31 March 2024

AddLife
Regulatory press release4/5/2024, 1:45 PM

AddLife's Annual Report for 2023 is now published

AddLife
Regulatory press release3/27/2024, 2:00 PM

Notice to attend the Annual General Meeting of AddLife AB (publ)

AddLife
Regulatory press release2/2/2024, 6:45 AM

AddLife: Year-end report 1 January - 31 December 2023

AddLife
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.